#Innovation dans le #cardiovasculaire - #Cardiovascular #Innovation

Digital health technology company Eko Health has introduced its next-generation digital stethoscope, the CORE 500.

Researchers at the University of California San Diego have developed a wearable ultrasound patch that is intended to provide information on the stiffness

Patients with occlusion myocardial infarction (OMI) and no ST-elevation on presenting electrocardiogram (ECG) are increasing in numbers. These patients have a poor prognosis and would benefit from immediate reperfusion therapy, but, currently, there are no accurate tools to identify them during initial triage. Here we report, to our knowledge, the first observational cohort study to develop machine learning models for the ECG diagnosis of OMI. Using 7,313 consecutive patients from multiple clinical sites, we derived and externally validated an intelligent model that outperformed practicing clinicians and other widely used commercial interpretation systems, substantially boosting both precision and sensitivity. Our derived OMI risk score provided enhanced rule-in and rule-out accuracy relevant to routine care, and, when combined with the clinical judgment of trained emergency personnel, it helped correctly reclassify one in three patients with chest pain. ECG features driving our models were validated by clinical experts, providing plausible mechanistic links to myocardial injury. A machine learning algorithm, developed to detect occlusion myocardial infarction with no-ST elevation from electrocardiogram, outperforms clinicians in diagnostic assessments.

The realm of Artificial Intelligence (AI) is limitless, with countless applications spreading across diverse sectors.

L'institut d'expertise Mobilab & Care de l'école supérieure Thomas More à Geel souhaite utiliser l'intelligence artificielle (IA) pour diagnostiquer précocement les maladies cardiovasculaires. Pour ce faire, il bénéficiera d'un financement européen de 1 million d'euros. L'institut utilisera comme base les nombreuses données collectées au fil des années par l'hôpital de Geel dans le cadre du traitement des patients atteints de maladies cardiovasculaires chroniques.

Le Risque cardiovasculaire ’absolu’ ou ’global’

Afin de soulager et d’aider patients et professionnels de santé, Arterya a développé une technologie révolutionnaire. Présentation.

Un jour, cette technique pourrait permettre d'imprimer des organes à la demande à partir des propres cellules d'un patient.

Researchers at The University of Texas at Austin successfully developed an e-tattoo for continuous mobile heart monitoring.

Ten years passed since Japan set out the Action Plan of Growth Strategy that declared the initiatives of digitalization for medicine, nursing care, and healthcare to achieve the world’s most advanced medical care. The initiatives formed the foundation of the Japanese national strategy and have been continuously refined, resulting in the current environment of digital health and digital medicine. Digital health–related terminologies are organized, such as “digital health,” “digital medicine,” and “digital therapeutics” (DTx), as well as several common digital technologies, including artificial intelligence, machine learning, and mobile health (mHealth). DTx is included in mHealth and is a novel disease treatment option. Also, this article thoroughly describes DTx in Japan and compares it with those in the US and Germany, the leading countries in digital health–related policies, regulations, and their development status. In Japan, two of three DTx applications that have been approved and reimbursed by the Ministry of Health, Labor, and Welfare are explained in detail in relation to cardiovascular medicine. When added to a standard smoking cessation program, the DTx system for nicotine dependence significantly improved the continuous abstinence rate. Moreover, the DTx for hypertension together with the guideline-based hypertension management was effective in patients aged 65 years or younger who were diagnosed with essential hypertension without antihypertensive agents, and it was also found to be cost-effective. DTx in cardiovascular medicine, with consideration on safety, efficacy, and cost-effectiveness, could be widely used not only through basic experiments and clinical studies but also through social implementation.

The deep learning-based model can accurately classify cardiac functions and valvular
heart diseases using information from digital chest radiographs. This model can classify
values typically obtained from echocardiography in a fraction of the time, with low
system requirements and the potential to be continuously available in areas where
echocardiography specialists are scarce or absent.

Cardiovascular disease (CVD) is the leading cause of death globally, accounting for nearly 18 million deaths each year.

A patent uncovered by tech site Pigtou and @xleaks7 shows that Samsung might be working on introducing health and biometric sensors on future foldable devices. A diagram shows what appears to be a Galaxy Z Flip model, which displays data for blood pressure and vascular age tracking, as well as arterial stiffness and other metrics.

Fitbit is considering the use of photoplethysmography (PPG) for pulse wave analysis via wearable tech, as suggested by a newly filed patent. This innovative approach might allow for a non-invasive measure of arterial stiffness, which is a key indicator of cardiovascular risk. It could also pave the way for blood pressure measurements from the wrist.

L’équipe du CHU de Toulouse est la première au monde à utiliser une toute nouvelle sonde d’échographie 3D miniaturisée. Une révolution pour soigner les anomalies cardiaques des petits patients.

25 innovations pour développer la prévention partout et pour tous

Conçue par l’équipe du Professeur Erwan Donal, cardiologue au CHU de Rennes, avec le soutien du Fonds Nominoë, Eva est un véritable assistant de santé qui informe et apporte des conseils personnalisés. Cette application accompagne les malades atteints d’une anomalie des valves cardiaques et sensibilise aussi l’entourage ou toutes les personnes curieuses d’apprendre davantage sur ces pathologies qui touchent 3 à 5 % de la population française.